Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease
Months 7-9: Seasonal Adaptation and Maintenance The third quarter often involves transitioning to maintenance protocols that sustain benefits while optimizing long-term cost-effectiveness and compliance
[01:53] Today we'll be diving deeper into treatment decisions, imaging pitfalls, and how to recognize when venous disease is masquerading as, quote, just POTS
Lacey Anderson said the first oral GLP-1 medication for weight loss, a pill version of Wegovy, received approval from the Food and Drug Administration in December 2025
What Is GLP-1 Microdosing
Because L-carnitine is known to be an essential co-factor in fatty acid and energy metabolism, and patients on dialysis tend to be malnourished, it might follow that repletion of L-carnitine by the intravenous or oral route could improve nutritional status, particularly among patients with low dietary L-carnitine intakes